Sagimet Biosciences Inc. (SGMT) stock
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.85−0.28 (-2.76%)
Close on Nov 17, 2026Market cap $612.26MP/E –Yield –
Sagimet Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sagimet Biosciences's revenue for the twelve months ending Dec 31, 2023 was $2.00M. For fiscal 2023 it was $2.00M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $2.00M | – |
See a number that looks wrong?